Proxeon

Proxeon is a Denmark-based biotechnology and hardware startup, founded in 2002, that specializes in developing cutting-edge solutions for the proteomics field. With a focus on addressing scientific and technical challenges, Proxeon aims to support researchers worldwide by delivering high-performance and innovative solutions for medical, pharmaceutical, and biotech research.

The company boasts a team of scientists with over 15 years of active involvement in proteomics research, equipped with specialized knowledge in biology, physics, engineering, and informatics. This expertise enables Proxeon to develop products that target critical bottlenecks in proteomic workflows, emphasizing superior performance, robustness, simplicity, and user-friendliness.

Proxeon's core competencies lie in mass spectrometry, protein analysis, and hardware and software design for proteome analysis, giving the company a unique edge in creating advanced proteomics tools. In February 2009, the company secured a $2.41M Venture Round investment from Vaekstfonden, Inventure Capital, and Vecata, further validating its potential for growth and impact in the biotech industry. With its strong track record and commitment to innovation, Proxeon remains poised to make significant contributions to the scientific community and beyond.